A Phase 1 Study of Halichondrin B Analog (E7389) in Combination With Cisplatin in Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 28 Oct 2014
At a glance
- Drugs Eribulin (Primary) ; Cisplatin
- Indications Solid tumours
- Focus Adverse reactions; Biomarker; Pharmacokinetics
- 19 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2013 Planned end date changed from 1 Dec 2012 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 08 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.